Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NeuroSense Therapeutics Ltd. Logo
A late-clinical stage company developing drugs for neurodegenerative diseases like ALS.
United States of America
NRSN
Newbury Pharmaceuticals AB Logo
A hybrid pharmaceutical company focused on specialty drugs in the Nordic region.
Sweden
NEWBRY
New Nordic Healthbrands AB Logo
Develops and markets herbal supplements, dietary supplements, and personal care products.
Sweden
NNH
Newron Pharmaceuticals S.p.A. Logo
Biopharmaceutical company developing therapies for nervous system disorders and pain.
Italy
NWRN
NEXGEL, INC. Logo
Manufactures skin-friendly hydrogel patches for healthcare, cosmetic, and wellness uses.
United States of America
NXGL
NEXTBIOMEDICAL Co., Ltd. Logo
Develops medical devices using a proprietary biodegradable polymer technology platform.
South Korea
389650
NextCell Pharma AB Logo
Develops cell therapies for autoimmune diseases and operates a private stem cell bank.
Sweden
NXTCL
NextCure, Inc. Logo
Clinical-stage biopharma developing novel, first-in-class immunomedicines for cancer.
United States of America
NXTC
Niagen Bioscience, Inc. Logo
A bioscience company focused on NAD+ science to support healthy aging.
United States of America
NAGE
NIBEC CO., LTD. Logo
Develops peptide-based biomaterials for regenerative medicine, dental, and cosmetic uses.
South Korea
138610

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.